Longer term safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus: systematic review and meta-analysis - Goossen, K; Graber, S (Diabetes, obesity & metabolism, 2012)
Keywords: adverse drug reactions; antidiabetic drug; Asthenia - chemically induced; Blood Glucose - drug effects; Cardiovascular Diseases - chemically induced; Confidence intervals; Diabetes; Diabetes Mellitus, Type 2 - drug therapy; Dipeptidyl-Peptidase IV Inhibitors - administration & dosage; Dipeptidyl-Peptidase IV Inhibitors - adverse effects; DPP-IV inhibitor; Drug Monitoring; Humans; Hypoglycemic Agents - administration & dosage; Hypoglycemic Agents - adverse effects; meta-analysis; Odds Ratio; Randomized Controlled Trials as Topic; Sulfonylurea Compounds - administration & dosage; Sulfonylurea Compounds - adverse effects; Treatment Outcome; type 2 diabetes; antidiabetic drug; adverse drug reactions; type 2 diabetes; DPP‐IV inhibitor; meta‐analysis